Clinical Trial Update: XIENCE V: SPIRIT WOMEN [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for XIENCE V in the SPIRIT WOMEN study, which has completed. The trial evaluated outcomes of the XIENCE V everolimus-elu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis
• Coronary Atherosclerosis
• Coronary Restenosis
• Myocardial Ischemia
• Stent Thrombosis
• Total Occlusion of the Coronary Artery
• Vascular Disease

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Status: COMPLETED